Autopsy report · NCT01279369

The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

“Quantitative assessment of fFN only able to be performed at one laboratory.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months after it had already started.
• Ran for about 3 years before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Winthrop University Hospital

Sponsor type

University, hospital or other

Conditions

Pregnancy Related; Trauma; Abruptio Placentae

Participants

3

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.